Contact Information
- Phone
- (713) 255-1991
- info@surgescientific.com
- Company
- Surge Scientific
12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup – 90 mL | AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP & THC
In Stock
$5.99$2.70/each
Quantity
1
Description
12 DRUG PANELS • PCP, MDMA & BUP • COMPACT 90 mL
12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup
Comprehensive preliminary urine drug screening in a compact, space-saving 90 mL cup.
This self-contained test cup screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine and marijuana.
Dedicated PCP, MDMA, BUP, MTD, OPI and OXY panels provide broad screening across stimulants, sedatives, opioids, hallucinogens and marijuana. The compact design supports easy handling and storage while delivering preliminary results in approximately five minutes.
Product Highlights
Twelve-Drug Screening Screens for AMP/1000, OPI/300, MET/1000, BZO/300, COC/300, MTD/300, OXY/100, BUP/10, MDMA/500, THC/50, BAR/300, PCP/25
Dedicated PCP Panel Screens for phencyclidine at the manufacturer-listed 25 ng/mL cutoff.
Dedicated MDMA Panel Screens for MDMA or ecstasy at the listed 500 ng/mL cutoff.
Buprenorphine Screening Includes a separate BUP panel at the listed 10 ng/mL cutoff.
Expanded Opioid Coverage Includes dedicated BUP, MTD, OPI and OXY screening panels.
Results in 5 Minutes Provides clear preliminary results for efficient onsite screening.
Compact 90 mL Capacity Provides sufficient specimen capacity in an easy-to-store format.
One-Step Testing Collection and preliminary screening are completed using one device.
Leak-Resistant Lid Secure closure helps reduce spills, leakage and accidental opening.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Single-Use Format Designed for hygienic, one-time specimen collection and preliminary screening.
Manufacturer-Stated Accuracy Manufacturer information reports up to 99% accuracy when used as directed.
Drug Panels and Cutoff Levels
Review the twelve drug categories and manufacturer-listed preliminary screening cutoff levels.
| TEST STRIP | TESTED DRUG | ESTIMATED DETECTION TIME / CUTOFF |
|---|---|---|
|
AMP AMP AMP AMP AMP
AMP AMP AMP AMP AMP |
Amphetamines | 1–2 Days • 1,000 ng/mL |
|
BAR BAR BAR BAR BAR
BAR BAR BAR BAR BAR |
Barbiturates | 1–4 Days • 300 ng/mL |
|
BUP BUP BUP BUP BUP
BUP BUP BUP BUP BUP |
Buprenorphine | 2–6 Days • 10 ng/mL |
|
BZO BZO BZO BZO BZO
BZO BZO BZO BZO BZO |
Benzodiazepines | 1–2 Days • 300 ng/mL |
|
COC COC COC COC COC
COC COC COC COC COC |
Cocaine | 2–4 Days • 300 ng/mL |
|
MDMA MDMA MDMA MDMA
MDMA MDMA MDMA MDMA |
MDMA / Ecstasy | 2–4 Days • 500 ng/mL |
|
MET MET MET MET MET
MET MET MET MET MET |
Methamphetamine | 2–4 Days • 1,000 ng/mL |
|
MTD MTD MTD MTD MTD
MTD MTD MTD MTD MTD |
Methadone | 1–3 Days • 300 ng/mL |
|
OPI OPI OPI OPI OPI
OPI OPI OPI OPI OPI |
Morphine / Opiates | 2–3 Days • 300 ng/mL |
|
OXY OXY OXY OXY OXY
OXY OXY OXY OXY OXY |
Oxycodone | 1–3 Days • 100 ng/mL |
|
PCP PCP PCP PCP PCP
PCP PCP PCP PCP PCP |
Phencyclidine | 7–14 Days • 25 ng/mL |
|
THC THC THC THC THC
THC THC THC THC THC |
Marijuana | 5+ Days • 50 ng/mL |
Please Note: Detection windows vary according to dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors.Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity information and interpretation instructions.
Dedicated PCP Screening The PCP panel provides preliminary screening for phencyclidine at the manufacturer-listed 25 ng/mL cutoff. It does not measure concentration or indicate the timing or degree of exposure.
Separate BUP, MTD, OPI and OXY Panels Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated strips provide targeted preliminary screening for each listed analyte.
Compact Without Sacrificing Coverage The 90 mL format combines specimen collection, temperature verification and twelve-panel screening while requiring less storage space than a standard 120 mL cup.
How to Use the 12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup
Understanding the 12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup Results
Product Dimensions and Specifications
| 12-Panel PCP, MDMA & Buprenorphine Compact Drug Test Cup | |
| Drug panels | AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY, PCP and THC |
| Buprenorphine cutoff | BUP/10 |
| MDMA cutoff | MDMA/500 |
| Opiate cutoff | OPI/300 |
| Oxycodone cutoff | OXY/100 |
| PCP cutoff | PCP/25 |
| Result time | Approximately 5 minutes |
| Capacity | 90 mL |
| Height | 6.5 cm |
| Width | 5.4 cm |
| Lid width | 7 cm |
| Approximate weight | 0.18 lb |
| Use | Single-use urine collection and preliminary screening device |
CLIA Waived and FDA 510(k) Cleared
According to the supplied manufacturer information, this exact 12-panel configuration is CLIA Waived and FDA 510(k) Cleared for the intended uses identified in its labeling. Confirm the regulatory status printed on the exact product packaging before advertising or use.
What CLIA Waived Means Eligible point-of-care sites may use the test under a CLIA Certificate of Waiver when the manufacturer’s instructions and applicable federal, state and local requirements are followed.
What FDA 510(k) Cleared Means The device completed the applicable FDA premarket-clearance process and was found substantially equivalent to a legally marketed predicate for its labeled intended use.
Depending on its exact labeling and applicable requirements, this cup may be suitable for physician offices, healthcare facilities, occupational health clinics, treatment and rehabilitation programs, drug-testing collection sites, probation and correctional programs and qualifying workplace-screening programs.
Regulatory Notice: FDA clearance and CLIA-waived status are separate designations. Regulatory status may vary by exact cup configuration or individual assay, and state or local requirements may apply.
Frequently Asked Questions
1. Which substances does this 12-panel cup screen for? It screens for amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, phencyclidine and marijuana.
2. Does this cup include a separate PCP panel? Yes. It includes dedicated phencyclidine screening at the manufacturer-listed cutoff of 25 ng/mL.
3. Why are BUP, MTD, OPI and OXY tested separately? Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Separate strips provide targeted preliminary screening.
4. Does the smaller 90 mL format affect the panel coverage? No. The compact cup still provides sufficient specimen capacity for the integrated twelve-panel screening process when used according to the package insert.
5. Does the temperature strip prove specimen authenticity? No. It measures specimen temperature shortly after collection and helps identify samples outside the expected range. It does not independently prove authenticity or detect every form of tampering.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, legal or treatment decisions are made.
Twelve Drug Panels. PCP, MDMA and Buprenorphine Screening. Compact 90 mL Design. Simplify preliminary urine drug screening with a compact, self-contained cup designed for broad panel coverage, secure collection and easy visual interpretation.
Shipping & Delivery
- All orders will be shipped the same day if placed before 3:00 PM EST.
- Next-day shipments will not be delivered on weekends, and the time taken on air shipments should be counted as business days.
Why order from us
- CLIA-waived screening supplies for qualified lab and point-of-care workflows.
- Same-day shipping on orders placed before 3:00 PM EST.
- Volume and bulk pricing available — contact us for recurring supply.